Esbriet

Related

• Esbriet-(Pirfenidone)-–-Advanced-Therapy-for-Idiop
  Esbriet (pirfenidone) is an FDA-approved oral medication designed to slow the progression of idiopathic pulmonary fibrosis (IPF), a chronic and debilitating lung disease. Clinically proven to reduce lung function decline, Esbriet offers hope to patients by targeting fibrosis pathways and improving quality of life. With its well-tolerated profile and robust efficacy data, Esbriet stands as a cornerstone in IPF management. Key Specifications Active Ingredient: Pirfenidone Dosage Forms: 267 mg and 801 mg tablets Recommended Dosage: 801 mg three times daily (2403 mg/day) Mechanism of Action: Anti-fibrotic, modulating TGF-β and TNF-α pathways Storage Conditions: Room temperature (15–30°C), protect from light Manufacturer: Genentech/Roche FDA Approval: 2014 (USA), 2011 (EU) Clinical Advantages of Esbriet 1.
• Pirfenex-(Pirfenidone)-–-Advanced-Antifibrotic-The
  Introduction Pirfenex (Pirfenidone) is a breakthrough oral medication designed to slow the progression of idiopathic pulmonary fibrosis (IPF), a chronic and debilitating lung disease. Clinically proven to reduce lung function decline, Pirfenex offers hope to patients by targeting fibrosis pathways, improving quality of life, and extending survival rates. With its well-tolerated profile and FDA/EMA approval, Pirfenex stands as a first-line therapy in IPF management. Technical Specifications Active Ingredient: Pirfenidone (267 mg or 801 mg per capsule/tablet) Dosage Form: Film-coated tablets or capsules Recommended Dosage: 801 mg three times daily (2403 mg/day) Mechanism of Action: Inhibits TGF-β and TNF-α, reducing collagen deposition Bioavailability: >80% (oral administration) Half-life: ~2.
• A-Ret-Gel-–-Advanced-Dermatological-Treatment-for-
  A Ret Gel is a clinically formulated retinoid-based topical treatment designed to promote skin cell turnover, reduce fine lines, and improve overall skin texture. Developed with medical-grade precision, this gel harnesses the power of stabilized retinol to deliver visible results without excessive irritation. Ideal for dermatologist-recommended regimens, A Ret Gel is a trusted solution for acne-prone, aging, and hyperpigmented skin. Technical Specifications Active Ingredient: Tretinoin (0.025%, 0.05%, 0.1%) Formulation: Lightweight, non-comedogenic gel Absorption: Fast-absorbing, non-greasy pH Level: Optimized for skin compatibility (pH 5.
• Abana-–-Advanced-Medical-Diagnostic-Device-for-Pre
  Abana is a cutting-edge medical diagnostic device designed to deliver accurate, real-time health monitoring and analysis. Engineered for healthcare professionals and clinics, Abana combines high-performance hardware with intelligent software to streamline diagnostics, enhance patient care, and improve clinical efficiency. With its state-of-the-art display, powerful processor, and extensive memory, Abana sets a new standard in medical technology. Technical Specifications Display: 10.4" Full HD (1920x1200) touchscreen with anti-glare coating for clear visibility in any lighting.
• Abhigra-–-Advanced-Medical-Diagnostic-Tablet-for-P
  The Abhigra is a state-of-the-art medical-grade tablet designed for healthcare professionals, offering unparalleled precision, efficiency, and reliability in clinical diagnostics. Engineered with cutting-edge technology, it ensures seamless integration into medical workflows, providing real-time data analysis, high-resolution imaging, and secure patient management. Whether for telemedicine, point-of-care diagnostics, or hospital use, the Abhigra sets a new standard in medical technology. Technical Specifications Display: 12.4" AMOLED touchscreen 2560 × 1600 resolution (WQXGA) Anti-glare coating for optimal visibility in clinical settings Corning Gorilla Glass 6 for durability Performance:
• Abilify-(Aripiprazole)-–-Expert-Medical-Overview
  Introduction Abilify (aripiprazole) is a leading atypical antipsychotic medication designed to treat a range of psychiatric conditions, including schizophrenia, bipolar disorder, major depressive disorder (as an adjunct), and irritability associated with autism. Developed with a unique mechanism of action as a partial dopamine agonist, Abilify offers superior symptom control with a reduced risk of side effects compared to traditional antipsychotics. Key Specifications Active Ingredient Aripiprazole Available Forms Tablets: 2 mg, 5 mg, 10 mg, 15 mg, 20 mg, 30 mg Orally Disintegrating Tablets (Abilify Discmelt) Oral Solution (1 mg/mL) Injectable (Abilify Maintena – extended-release) Mechanism of Action Partial agonist at dopamine D₂ and serotonin 5-HT₁A receptors Antagonist at serotonin 5-HT₂A receptors Dosage & Administration Schizophrenia: 10–15 mg/day (max 30 mg/day) Bipolar Disorder: 15–30 mg/day Adjunct for MDD: 2–5 mg/day Autism-Related Irritability: 5–15 mg/day Half-Life & Metabolism Half-life: ~75 hours (active metabolite) Metabolism: Hepatic (CYP3A4, CYP2D6) Advantages of Abilify ✅ Superior Efficacy – Clinically proven to reduce hallucinations, mood swings, and agitation with high response rates.